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Abstract
Background: Colonization or infection with multi-drug resistant (MDR) bacteria is considered detrimental to the
outcome of neurological and neurosurgical early rehabilitation patients.
Methods: In a German multi-center study, 754 neurological early rehabilitation patients were enrolled and and
reviewed in respect to MDR status, length of stay (LOS) and the following outcome variables: Barthel Index (BI),
Early Rehabilitation Index (ERI), Glasgow Outcome Score Extended (GOSE), Coma Remission Scale (CRS), Functional
Ambulation Categories (FAC).
Results: The mean age of the study population was 68.0 ± 14.8 years. Upon admission, the following prevalence for
MDRs was observed: MRSA (methicillin resistant staphylococcus aureus) 7.0% (53/754), ESBL- (extended spectrum
beta-lactamase) producing bacteria strains 12.6% (95/754), VRE (vancomycin resistant enterococci) 2.8% (21/754).
Patients colonized or infected with MDR bacteria (MDR+) were significantly more frequently diagnosed with a
critical illness polyneuropathy – CIP – than non-colonized (MDR-) patients: 29.0% vs. 14.8%. In addition, they were
more frequently mechanically ventilated (MDR+: 55/138, 39.9%; MDR- 137/616, 22.2%). MDR+ patients were referred
to rehabilitation earlier, had a longer LOS in early rehabilitation, lower BI on admission and at discharge, lower ERI
on admission and lower CRS at discharge than MDR- patients. There was a highly significant correlation of the BI
upon admission with the BI at discharge (rs = 0.492, p < 0.001). GOSE at discharge differed significantly between
both groups (χ2-test, p < 0.01). Perhaps of greatest importance, mortality among MDR+ was higher in comparison to
MDR- (18.1% vs. 7.6%).
Conclusions: The outcome of neurological early rehabilitation patients colonized or infected with MDR bacteria
including MRSA or ESBL producing strains is significantly poorer than by non-colonized patients. There is some
evidence that the poor outcome could be related to the higher morbidity and lower functional status upon
admission.
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Background
In Germany, there exist an increasing number of
specialized hospitals for early neurological and neuro-
surgical rehabilitation. These hospitals continue inten-
sive and intermediate care treatment of patients who
have been treated in intensive care units of acute-care
facilities, who do not require specialized interventions
but are still dependent on an intensive care setting.
Many patients cared for in neurological and neurosur-
gical early rehabilitation facilities were previously
treated in non-neurological/non-neurosurgical clinics,
most of them suffering from neurological complica-
tions including critical illness polyneuropathy (CIP),
hypoxic or septic encephalopathy [1].
Colonization and/or infection with multi-drug re-
sistant (MDR) bacteria including methicillin resistant
Staphylococcus aureus (MRSA) or extended spectrum
beta-lactamase (ESBL) producing gram-negative strains is
a challenge in neurological and neurosurgical early re-
habilitation. To date, it has been shown that MRSA preva-
lence upon admission ranges from 7.0 to 14.5% [1–3],
whereas colonization with ESBL producing bacteria
from 12.6 to 14.0% [1, 3, 4]. Other MDR strains in-
cluding vancomycin-resistant enterococci (VRE) play a
minor role, being present in only approximately 2.8%
of cases [1].
This means that almost every fourth patient entering
neurological early rehabilitation is either colonized or in-
fected with multi-drug resistant bacteria [1–4].
When a patient with MRSA or ESBL-producing bacteria
is admitted, contact precautions (isolation) are recom-
mended in Germany, in particular on intensive or inter-
mediate care units [5, 6]. Obviously, isolation measures in
rehabilitation facilities raise ethical concerns [7], due to
their being responsible for symptoms of psychological
distress including depression and anxiety [8]. Isolation
measures interfere with the traditional rehabilitative
approach and may cause poorer outcomes [7].
The impact of contact precautions on the outcome
of neurological early rehabilitation patients was re-
cently investigated in two single-center studies [9, 10].
It was shown that functional recovery of patients col-
onized or infected with either MRSA or ESBL-
producing bacteria was poorer than in non-colonized
patients [9, 10]. However, the poorer outcome was
not a result of less therapy (due to isolation) but due
to the lower functional status and higher morbidity
upon admission [9, 10].
The present paper is based upon data from a 2014
German multi-center study on neurological and
neurosurgical early rehabilitation [1]. The focus of
the present investigation was to analyze the influence
of multi-drug resistant bacteria upon the outcome of
the rehabilitation measure.
Methods
The multi-center study collected data prospectively from
754 patients admitted to 16 German neurological early
rehabilitation centers in March, 2014 [1]. Prevalence of
patients carrying MDR bacteria (colonization or infection)
on admission was documented.
Age, gender, primary diagnosis, medical devices, Glas-
gow Coma Scale (GCS) [11], Coma Remission Scale
(CRS) [12], Barthel Index (BI) [13], Early Rehabilitation
Index (ERI) [14] and FAC (Functional Ambulation
Categories) [15] on admission and at discharge were
documented. In addition, Glasgow Outcome Scale-
Extended (GOSE) [16] was obtained at discharge.
Statistics: Since main variables such as BI on admis-
sion and at discharge were not normally distributed,
non-parametric testing was performed. Statistical ana-
lyses included χ2-, Mann-Whitney-U-tests for independ-
ent samples and Spearman-Rho correlations. Differences
were regarded as significant with p < 0.05. Nonetheless, in
the results section, mean values and standard deviations
are displayed.
Results
The mean age of the whole study sample was 68.0 ±
14.8 years; 297 (39.4%) subjects were female. On ad-
mission, MRSA prevalence was 7.0% (53/754), ESBL-
producing bacteria were present in 12.6% (95/754),
while VRE were found in only 2.8% (21/754) of cases.
Carriers of MRSA, ESBL-producing germs or VRE were
assigned to the multi-drug resistant positive (MDR+)
group (138/754, 18.3%), all other patients were regarded
as MDR negative (MDR-). 31 MDR+ patients were colo-
nized with more than one MDR strain.
Primary diagnoses and characteristics of MDR+ and
MDR- patients are to be found in Tables 1 and 2.
Diagnoses were unequally distributed between
MDR+ and MDR- (χ2-test, p < 0.001), Table 1. The
Table 1 Primary diagnoses of early rehabilitation patients with
(MDR+) and without (MDR-) multi-drug resistant (MDR) bacteria
MDR+ MDR- Sum
Polyneuropathy or other peripheral
nerve impairment
40 (29.0%) 91 (14.8%) 131
Ischemic stroke 32 (23.2%) 207 (33.6%) 239
Intracranial hemorrhage 22 (15.9%) 132 (21.4%) 154
Traumatic brain injury 14 (10.1%) 73 (11.9%) 87
Hypoxia 9 (6.5%) 38 (6.2%) 47
Spinal cord injury 9 (6.5%) 19 (3.1%) 28
Brain tumor 3 (2.2%) 18 (2.9%) 21
Other primary diagnosis 9 (6.5%) 38 (6.2%) 47
Sum 138 (100%) 616 (100%) 754
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most frequent diagnosis among MDR+ was critical-
illness polyneuropathy (CIP) and a higher proportion
of MDR+ patients suffered from CIP compared to
MDR- (29.0% vs. 14.8%). This finding could be ex-
plained by the fact that relatively more MDR+ were
mechanically ventilated on admission (MDR+: 55/
138, 39.9%; MDR- 137/616, 22.2%) and CIP was the
leading diagnosis among ventilated patients (71/192,
37.0%). Ventilated patients had a significantly lower BI on
admission (p < 0.001) and at discharge (p < 0.001) than
spontaneously breathing patients.
MDR+ patients were referred to rehabilitation earlier,
had a longer length of stay (LOS) in early rehabilitation,
lower BI on admission and at discharge, lower ERI on
admission and lower CRS at discharge, Table 2. BI upon
admission correlated significantly with BI at discharge
(rs = 0.492, p < 0.001). The older the patients, the lower the
BI at discharge was documented (rs = −0.174, p < 0.001).
However, MDR+ and MDR- did not differ significantly
with respect to age (Table 2).
GOSE at discharge differed significantly between both
groups (χ2-test, p < 0.01), in particular mortality among
MDR+ was higher compared to MDR- (18.1% vs. 7.6%),
Table 3.
Neither FAC on admission (Table 4) nor at dis-
charge (Table 5) differed significantly between both
groups (χ2-test, n.s.).
Discussion
The high prevalence of MDR bacteria is an emerging
challenge in neurological and neurosurgical early re-
habilitation. In the present study, 18.3% of all patients
were either colonized or infected with MDR bacteria
upon admission. While MRSA prevalence (7.0%) was
lower than reported before [2, 3], colonization with
MDR gram negative strains (12.6%) was in line with pre-
vious studies [2, 4]. MRSA and ESBL producing bacteria
proved to be quite common, whereas the VRE preva-
lence was less than 3%.
It has previously been shown in a single-center study
that patients with MRSA or ESBL-producing germs are at
risk for a poor outcome [9, 10]. The present multi-center
Table 2 Characteristics of MDR+ and MDR- neurological early
rehabilitation patients
MDR+ MDR- p-value*
N 138 616 -
Sex (m/w) 90/48 367/249 n.s.**
Age [years] 67.9 (13.7) 68.0 (15.0) n.s.
Disease onset [days prior
to admission]
51.5 (59.9) 75.1 (557.8) <0.001
Length of stay in neurological
early rehabilitation [days]
69.0 (64.7) 54.3 (46.3) <0.01
Barthel Index (BI) on admission
[0 to 100]
4.7 (7.3) 9.3 (11.9) <0.001
BI at discharge [0 to 100] 20.0 (22.4) 26.2 (22.8) <0.01
Λ BI (discharge-admission) 15.3 (21.5) 16.8 (19.5) n.s.
Early Rehabilitation Index (ERI)
on admission [−325 to 0]
−129.0 (86.6) −108.8 (84.3) <0.05
ERI at discharge [−325 to 0] −62.5 (75.4) −53.5 (63.8) n.s.
Λ ERI (discharge-admission) 55.3 (74.0) 66.5 (82.5) n.s.
Coma Remission Scale (CRS)
on admission [0 to 24]
17.8 (7.8) 18.4 (7.4) n.s.
CRS at discharge [0 to 24] 18.1 (9.2) 20.3 (7.4) <0.05
Λ CRS (discharge-admission) 0.0 (9.5) 1.6 (7.3) n.s.
Glasgow Coma Scale (GCS)
on admission [3 to 15]
11.5 (3.8) 11.8 (3.6) n.s.
GCS at discharge [3 to 15] 11.7 (4.7) 12.9 (3.6) n.s.
Λ GCS (discharge-admission) 0.1 (4.9) 1.1 (3.4) n.s.
Mean and standard deviation are displayed
* Mann-Whitney-U-test, ** χ2-test, n.s. = not significant (p > 0.05)
Table 3 Glasgow Outcome Scale - Extended (GOSE) at
discharge
GOSE MDR+ MDR- Sum
1 death 25 (18.1%) 47 (7.6%) 72 (9.5%)
2 vegetative state 12 (8.7%) 45 (7.3%) 57 (7.6%)
3 lower severe disability 41 (29.7%) 246 (39.9%) 287 (38.1%)
4 upper severe disability 58 (42.0%) 257 (41.7%) 315 (41.8%)
5 lower moderate disability 2 (1.4%) 21 (3.4%) 23 (3.1%)
6 upper moderate disability 0 0 0
7 lower good recovery 0 0 0
8 upper good recovery 0 0 0
Sum 138 (100%) 616 (100%) 754 (100%)
Table 4 Functional Ambulation Categories (FAC) upon admission
FAC MDR+ MDR- Sum
0 - patient cannot walk 128 (92.8%) 541 (88.1%) 669 (89.0%)
1 - patients needs firm
continuous support from 1
person who helps carrying
weight and with balance
6 (4.3%) 45 (7.3%) 51 (6.8%)
2 - patient needs continuous or
intermittent support of one
person to help with balance
and coordination.
2 (1.4%) 18 (2.9%) 20 (2.7%)
3 - patient requires verbal
supervision or stand-by
help from one person
without physical contact
2 (1.4%) 9 (1.5%) 11 (1.5%)
4 - patient can walk independently
on level ground, but requires
help on stairs, slopes or uneven
surfaces
0 1 (0.2%) 1 (0.1%)
5 - patient can walk independently
anywhere
0 0 0
Sum 138 (100%) 614 (100%) 752 (100%)
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data support this hypothesis. MDR+ had a significantly
worse functional status – as measured with the BI – at
discharge. While FAC did not show significant differences
between MDR+ and MDR-, the GOS was poorer among
carriers of MDR bacteria.
How are these data to be interpreted? First of all, func-
tional status on admission was lower among MDR+ pa-
tients. Some authors have suggested that low a functional
status upon admission may be one of the most important
predictors for a poor outcome [9, 10]. There was a clear,
highly significant correlation between BI on admission
and at discharge in the present study sample. Further-
more, ERI on admission was lower in the MDR+ group.
The ERI provides a good estimate of early rehabilitation
patients’ morbidity [14, 17]. In addition, we found that
among patients on mechanical ventilation, a significantly
higher proportion of patients were MDR+. It is well
known that mechanically ventilated patients have a higher
morbidity, mortality and poorer outcome in neurological
early rehabilitation [1, 18, 19].
In addition, improvements in the assessments (ERI,
CRS and GCS) from admission to discharge were not
differing between MDR+ and MDR- groups. As far as
the changes in BI (discharge minus admission) are
concerned, it has to be pointed out that there were no
significant differences between the groups, either. So,
MDR+ patients benefitted from neurological early re-
habilitation, despite lower functional status on admission
and contact precautions.
Another finding was that MDR+ patients were referred
earlier to rehabilitation from acute-care hospitals than
MDR-. One possible explanation for this finding is the fact
that colonization with MDR bacteria pose a significant
economic burden, since patients colonized with MRSA
and ESBL producing bacteria have to be frequently iso-
lated, thus occupying hospital beds [3]. This might con-
tribute to earlier transfers to rehabilitation facilities in
order to minimize financial losses in acute-care hospitals.
In addition, patients requiring prolonged weaning from
mechanical ventilation are steadily increasing in early re-
habilitation facilities [1, 18, 19]. Overall, this is a welcome
trend since neurologically impaired patients, e.g., follow-
ing stroke, may profit from an early transfer [20]. Further
studies are required on the impact of MDR bacteria on
the outcome of neurological and neurosurgical early
rehabilitation patients.
Conclusions
The outcome of neurological early rehabilitation patients
with multi-drug resistant (MDR) bacteria such as MRSA
or ESBL producing strains is poorer than by non-
colonized patients. There is some evidence that the poor
outcome may be explained by higher morbidity and
lower functional status on admission.
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